TOTACILLIN Drug Patent Profile
✉ Email this page to a colleague
When do Totacillin patents expire, and when can generic versions of Totacillin launch?
Totacillin is a drug marketed by Glaxosmithkline and is included in six NDAs.
The generic ingredient in TOTACILLIN is ampicillin sodium. There are seventy drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the ampicillin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Totacillin
A generic version of TOTACILLIN was approved as ampicillin sodium by SANDOZ on February 19th, 1987.
Summary for TOTACILLIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 6 |
Raw Ingredient (Bulk) Api Vendors: | 78 |
Patent Applications: | 4,171 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TOTACILLIN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for TOTACILLIN
US Patents and Regulatory Information for TOTACILLIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glaxosmithkline | TOTACILLIN | ampicillin/ampicillin trihydrate | CAPSULE;ORAL | 060060-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glaxosmithkline | TOTACILLIN | ampicillin/ampicillin trihydrate | FOR SUSPENSION;ORAL | 060666-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glaxosmithkline | TOTACILLIN | ampicillin/ampicillin trihydrate | CAPSULE;ORAL | 062212-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |